Cardiovascular Disease

Acute Kidney Injury in CCU Patients Linked to Cystatin C

Acute Kidney Injury in CCU Patients Linked to Cystatin C

By

Among patients admitted to a coronary care unit, the highest quartile of serum cystatin C levels was associated with a 9.6-fold increased risk of AKI compared with the lowest quartile.

High ESA and Iron Doses Up CVD, Death Risk in Hemodialysis Patients

High ESA and Iron Doses Up CVD, Death Risk in Hemodialysis Patients

By

High doses of iron are associated with a significantly higher risk of cardiovascular disease, regardless of the dose of erythropoiesis-stimulating agent.

Severe Hypoglycemia a Red Flag for Cardiovascular Risks

Severe Hypoglycemia a Red Flag for Cardiovascular Risks

Severe hypoglycemia is associated with coronary heart disease, cardiovascular mortality, and cancer mortality.

CVD Hospitalization Rates Have Declined for Diabetes Patients

CVD Hospitalization Rates Have Declined for Diabetes Patients

For patients with diabetes, there was a significant decrease in hospitalization rates for acute coronary syndrome, cardiac dysrhythmia, heart failure, and certain strokes.

Coffee Benefits May Outweigh Risks

Coffee Benefits May Outweigh Risks

Coffee consumption was affiliated with more positives than negatives across a wide range of health outcomes.

Acute Kidney Injury Predicts Heart Failure

Acute Kidney Injury Predicts Heart Failure

By

In a study of hospitalized US veterans, AKI was associated with a 23% increased risk of heart failure compared with the absence of AKI.

Nut Consumption Tied With Lower Heart Disease Risk

Nut Consumption Tied With Lower Heart Disease Risk

Both total intake of nuts and consumption of peanuts/tree nuts and walnuts tied to lower risk.

Statins Reduce Risk of MACE in Patients With ASCVD

Statins Reduce Risk of MACE in Patients With ASCVD

Reduced frequency of MACE for patients receiving statins, especially high-intensity statins.

Waist-to-hip Ratio Predicts CV Mortality in Hemodialysis Patients

Waist-to-hip Ratio Predicts CV Mortality in Hemodialysis Patients

By

Each 0.1 increase in WHR is associated with a 1.7-fold increased risk of cardiovascular death.

Hypertension, Diabetes at Hemodialysis Initiation Increasing

Hypertension, Diabetes at Hemodialysis Initiation Increasing

By

From 1995 to 2015, the prevalence of hypertension and diabetes among patients starting hemodialysis increased from 67.9% to 87.6% and from 43.1% to 59.6%, respectively.

Post-Dialysis Survival Odds Better After CABG vs PCI

Post-Dialysis Survival Odds Better After CABG vs PCI

By

US veterans who underwent coronary artery bypass grafting versus percutaneous coronary intervention prior to starting dialysis had a 28% lower risk of death.

Statins May Raise Odds of Type 2 Diabetes in Those at High Risk

Statins May Raise Odds of Type 2 Diabetes in Those at High Risk

In any Diabetes Prevention Program treatment group, statin use tied to increased diabetes risk.

Sudden Cardiac Death Top Culprit in Diabetes With Atherosclerosis

Sudden Cardiac Death Top Culprit in Diabetes With Atherosclerosis

27% of CV deaths in diabetes patients with atherosclerotic CVD are categorized as sudden death.

Greater Heart Disease Benefits From Yoga Aerobics Combo

Greater Heart Disease Benefits From Yoga Aerobics Combo

Greater improvement in CHD risk factors for combined intervention versus either alone.

Bleeding, Death Similar for DOAC vs Warfarin in VTE

Bleeding, Death Similar for DOAC vs Warfarin in VTE

Direct oral anticoagulants not linked to increased risk of major bleeding, death in venous thromboembolism

Prostate Cancer Hormone Therapy Ups Cardiac Risks

Prostate Cancer Hormone Therapy Ups Cardiac Risks

By

Exposure to androgen-deprivation therapy was associated with a nearly 2-fold increased risk of heart failure among men without pre-existing cardiovascular disease.

High Rates of Infective Endocarditis Found Among ESRD Patients

High Rates of Infective Endocarditis Found Among ESRD Patients

By

Hemodialysis patients had higher rates of infective endocarditis than peritoneal dialysis and kidney transplant patients.

Less Than 1 in 2 Patients Receives Approval for PCSK9i Rx

Less Than 1 in 2 Patients Receives Approval for PCSK9i Rx

Overall, therapy was received by just 30.9% of those prescribed PCSK9 inhibitors.

Halting Low-Dose Aspirin Increases Cardiovascular Events

Halting Low-Dose Aspirin Increases Cardiovascular Events

Findings in a large study of long-term low-dose aspirin users.

Statin Use Tied With Lower Death Risk in Elderly Men

Statin Use Tied With Lower Death Risk in Elderly Men

The researchers found that over the study period statin use was associated with an 18% lower risk of all-cause mortality and non-significantly lower risk of CVD events and stroke.

Statin, ACEI/ARB Nonadherence Dangerous After Heart Attack

Statin, ACEI/ARB Nonadherence Dangerous After Heart Attack

Adherence to beta-blockers may not be as beneficial to patients after myocardial infarction.

Anagliptin Improves LDL Partly Via ApoB-100 Suppression

Anagliptin Improves LDL Partly Via ApoB-100 Suppression

The results demonstrated a tendency for a decrease in LDL-C level at 24 weeks in the ANA group, and improvement was mediated through the suppression of apoB-100 synthesis.

Exenatide Does Not Increase Cardiovascular Risk in Type 2 Diabetes

Exenatide Does Not Increase Cardiovascular Risk in Type 2 Diabetes

Administration of exenatide in patients with type 2 diabetes at a wide range of cardiovascular risk appeared not to cause an increase in their overall cardiovascular risk.

Cardiovascular Drugs Not Tied to Cognitive Impairment

Cardiovascular Drugs Not Tied to Cognitive Impairment

The researchers found that there was no evidence of an independent correlation between impaired cognitive function and antihypertensive use.

No Difference in Cognitive Function With Evolocumab Plus Statins

No Difference in Cognitive Function With Evolocumab Plus Statins

No associations were seen between low-density lipoprotein cholesterol levels and cognitive changes in an exploratory analysis.

Anacetrapib May Reduce Coronary Events

Anacetrapib May Reduce Coronary Events

The use of anacetrapib resulted in a lower incidence of major coronary events than the use of placebo.

Many Older Adults With A-Fib Do Not Receive Anticoagulants

Many Older Adults With A-Fib Do Not Receive Anticoagulants

The researchers found that there was an increase in NOAC use over time, warfarin use did not change, and overall anticoagulant use increased.

Retinal Emboli Associated With CVD Risk Factors, Stroke, CKD

Retinal Emboli Associated With CVD Risk Factors, Stroke, CKD

Older age, Indian ethnicity, hypertension, chronic kidney disease, creatinine level, glomerular filtration rate, and history of stroke were associated with prevalent retinal emboli in multivariable-adjusted analysis.

Canakinumab 150 mg Linked With Fewer Recurrent Cardiac Events

Canakinumab 150 mg Linked With Fewer Recurrent Cardiac Events

Canakinumab at a dose of 150 mg every 3 months led to a significantly lower rate of recurrent cardiovascular events than placebo.

Prostate Cancer ADT Linked With Cardiovascular Risks, Depression

Prostate Cancer ADT Linked With Cardiovascular Risks, Depression

By

In a study, the risk for heart failure was 81% higher among patients who received androgen deprivation therapy.

Sign Up for Free e-newsletters